Skip to main content
. 2022 Dec 18;22(7):808–817. doi: 10.1080/15384101.2022.2154556

Figure 5.

Figure 5.

The expression of FAM138B in NSCLC tissues and the survival analysis of patients with high or low expression of FAM138B by Kaplan-Meier method. (a) the expression of FAM138B was significantly reduced in LUAD samples compared to normal samples provided by the starbase database. (b) the expression of FAM138B decreased in NSCLC tissues compared to normal tissues. (c) Lymph node metastasis was associated with low expression of FAM138B. (d) the expression of FAM138B in NSCLC patients with TNM stage (III-IV) was lower than that in stage I-II. (e) Within five years, the survival probability of NSCLC patients with high expression of FAM138B was higher than that of low expression of FAM138B (log-rank P = 0.001). (f) the expression of FAM138B and miR-105-5p was negatively correlated (r = −0.6916, P <0.0001). ***P <0.001. Data were analyzed by Student’s t-test. The correlation coefficient was determined using Pearson correlation. Survival analysis was performed using the log-rank test.